RAMM — Ramm Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- CA$1.79m
- CA$1.07m
- CA$3.36m
Annual cashflow statement for Ramm Pharma, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.
2021 October 31st | 2022 October 31st | 2023 October 31st | 2024 October 31st | 2025 October 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.11 | -21 | -7.72 | -16.5 | -8.91 |
| Depreciation | |||||
| Non-Cash Items | 1.57 | 13.9 | 2.36 | 9.83 | 4.45 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.983 | 0.079 | -0.366 | 1.47 | 2.67 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Cash from Operating Activities | -3.82 | -5.91 | -4.39 | -4 | -1.06 |
| Capital Expenditures | -0.43 | -0.168 | -0.062 | -0.047 | 0 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -6.4 | -0.984 | 0.189 | 0 | 1.22 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -6.83 | -1.15 | 0.127 | -0.047 | 1.22 |
| Financing Cash Flow Items | -0.01 | — | — | — | -0.009 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.19 | -0.354 | -0.41 | -0.258 | -0.154 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -10.9 | -7.38 | -4.66 | -4.3 | -0.01 |